Anti-Müllerian hormone and folliculogenesis

Molecular and Cellular Endocrinology

Volumn 234, Issue 1-2, 2005, Pages 81-86

  Visser, Jenny A ^a   Themmen, Axel P N ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anti M llerian hormone; Folliculogenesis; Ovarian reserve; Signaling

Indexed keywords

FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

CONFERENCE PAPER; FERTILITY; FERTILIZATION IN VITRO; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DEPENDENCE; HUMAN; IN VITRO STUDY; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 17044395459     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2004.09.008     Document Type: Conference Paper

References (32)

1. W.M. Baarends, J.T. Uilenbroek, P. Kramer, J.W. Hoogerbrugge, E.C. van Leeuwen, A.P. Themmen, and J.A. Grootegoed Anti-Mullerian hormone and anti-Mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth Endocrinology 136 1995 4951 4962
2. W.M. Baarends, M.J. van Helmond, M. Post, P.J. van der Schoot, J.W. Hoogerbrugge, J.P. de Winter, J.T. Uilenbroek, B. Karels, L.G. Wilming, and J.H. Meijers A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Mullerian duct Development 120 1994 189 197
3. T.R. Clarke, Y. Hoshiya, S.E. Yi, X. Liu, K.M. Lyons, and P.K. Donahoe Müllerian-inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression Mol. Endocrinol. 15 2001 946 959
4. A. de Vet, J.S. Laven, F.H. de Jong, A.P. Themmen, and B.C. Fauser Antimullerian hormone serum levels: a putative marker for ovarian aging Fertil. Steril. 77 2002 357 362
5. N. di Clemente, B. Goxe, J.J. Rémy, R.L. Cate, N. Josso, B. Vigier, and R. Salesse Inhibitory effect of AMH upon aromatase activity and LH receptors of granulosa cells of rat and porcine immature ovaries Endocrine 2 1994 553 558
6. N. di Clemente, C. Wilson, E. Faure, L. Boussin, P. Carmillo, R. Tizard, J.Y. Picard, B. Vigier, N. Josso, and R. Cate Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone Mol Endocrinol 8 1994 1006 1020
7. Durlinger, A., 2000. Ovarian follicle growth and development: role of anti-Mullerian hormone. In: Thesis, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Rotterdam.
8. A.L. Durlinger, M.J. Gruijters, P. Kramer, B. Karels, T.R. Kumar, M.M. Matzuk, U.M. Rose, F.H. de Jong, J.T. Uilenbroek, J.A. Grootegoed, and A.P. Themmen Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary Endocrinology 142 2001 4891 4899
9. A.L. Durlinger, P. Kramer, B. Karels, F.H. de Jong, J.T. Uilenbroek, J.A. Grootegoed, and A.P. Themmen Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary Endocrinology 140 1999 5789 5796
10. A.L. Durlinger, M.J. Gruijters, P. Kramer, B. Karels, H.A. Ingraham, M.W. Nachtigal, J.T. Uilenbroek, J.A. Grootegoed, and A.P. Themmen Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary Endocrinology 143 2002 1076 1084
11. A.L. Durlinger, J.A. Visser, and A.P. Themmen Regulation of ovarian function: the role of anti-Mullerian hormone Reproduction 124 2002 601 609
12. G.F. Erickson, and S. Shimasaki The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle Reprod. Biol. Endocrinol. 1 2003 9
13. L. Gouédard, Y.G. Chen, L. Thevenet, C. Racine, S. Borie, I. Lamarre, N. Josso, J. Massagué, and N. di Clemente Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor J. Biol. Chem. 2000
14. A. Gougeon Regulation of ovarian follicular development in primates: facts and hypotheses Endocr. Rev. 17 1996 121 155
15. S.P. Jamin, N.A. Arango, Y. Mishina, M.C. Hanks, and R.R. Behringer Requirement of Bmpr1a for Müllerian duct regression during male sexual development Nat. Genet. 32 2002 408 410
16. S.P. Jamin, N.A. Arango, Y. Mishina, M.C. Hanks, and R.R. Behringer Genetic studies of the AMH/MIS signaling pathway for Mullerian duct regression Mol. Cell Endocrinol. 211 2003 15 19
17. N. Josso, R.L. Cate, J.-Y. Picard, B. Vigier, N. di Clemente, C. Wilson, S. Imbeaud, R.B. Pepinsky, D. Guerrier, L. Boussin, L. Legeai, and D. Carre-Eusebe Anti-mullerian hormone: the Jost factor Rec. Progr. Horm. Res. 48 1993 1 59
18. M.M. Lee, and P.K. Donahoe Müllerian-inhibiting substance: a gonadal hormone with multiple functions Endocr. Rev. 14 1993 152 164
19. E.A. McGee, and A.J. Hsueh Initial and cyclic recruitment of ovarian follicles Endocr. Rev. 21 2000 200 214
20. Y. Mishina, R. Rey, M.J. Finegold, M.M. Matzuk, N. Josso, R.L. Cate, and R.R. Behringer Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation Genes Develop. 10 1996 2577 2587
21. S. Nef, and L.F. Parada Cryptorchidism in mice mutant for Insl3 Nat. Genet. 22 1999 295 299
22. J.F. Nelson, and L.S. Felicio Hormonal influences on reproductive aging in mice Ann. NY Acad. Sci. 592 1990 8 12 discussion 44-51
23. E. Rajpert-De Meyts, N. Jorgensen, N. Graem, J. Muller, R.L. Cate, and N.E. Skakkebaek Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells J. Clin. Endocrinol. Metab. 84 1999 3836 3844
24. G.J. Scheffer, F.J. Broekmans, M. Dorland, J.D. Habbema, C.W. Looman, and E.R. te Velde Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility Fertil. Steril. 72 1999 845 851
25. D.B. Seifer, D.T. MacLaughlin, B.P. Christian, B. Feng, and R.M. Shelden Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil. Steril. 77 2002 468 471
26. D.B. Seifer, R.T. Scott Jr., P.A. Bergh, L.K. Abrogast, C.I. Friedman, C.K. Mack, and D.R. Danforth Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone Fertil. Steril. 72 1999 63 65
27. E.R. te Velde, and P.L. Pearson The variability of female reproductive ageing Hum. Reprod. Update 8 2002 141 154
28. I.A. van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, F.H. de Jong, and A.P. Themmen Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve Hum. Reprod. 17 2002 3065 3071
29. J.A. Visser, R. Olaso, M. Verhoef-Post, P. Kramer, A.P. Themmen, and H.A. Ingraham The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling Mol. Endocrinol. 15 2001 936 945
30. C. Weenen, J.S. Laven, A.R. Von Bergh, M. Cranfield, N.P. Groome, J.A. Visser, P. Kramer, B.C. Fauser, and A.P. Themmen Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Mol. Hum. Reprod. 10 2004 77 83
31. S.E. Yi, P.S. LaPolt, B.S. Yoon, J.Y. Chen, J.K. Lu, and K.M. Lyons The type I BMP receptor BmprIB is essential for female reproductive function Proc. Natl. Acad. Sci. U.S.A. 98 2001 7994 7999
32. S. Zimmermann, G. Steding, J.M. Emmen, A.O. Brinkmann, K. Nayernia, A.F. Holstein, W. Engel, and I.M. Adham Targeted disruption of the Insl3 gene causes bilateral cryptorchidism Mol. Endocrinol. 13 1999 681 691